Essential Medicinal Chemistry of Essential Medicines
Open accessThe DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Since 1977, the World Health Organization publishes a list of essential medicines, i.e., those that satisfy the priority health care needs of the population and are selected with regard to disease prevalence and public health relevance, evidence of clinical efficacy, and safety, as well as comparative costs and cost-effectiveness. The Essential Medicines List (EML) is an invaluable tool for all countries to select those medicines that have an excellent risk/benefit ratio and that are reputed to be of pivotal importance to health. In the present perspective, we describe the chemical composition and the main features of the small molecules that are included in the EML, spanning from their origin, to their stereochemistry and measure of drug-likeness. Most and foremost, we wish to disseminate the importance of the EML, which can be both a helpful teaching tool in an ever-expanding world of medicines and an inspiration for those involved in pharmaceutical R&D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N2O is one of the World Health Organization’s essential medicines, and its clinical administration has been considered safe for more than 150 years [125].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Research works printed but not linked: 4
- 2020, OMEGA2
- Csuk, 2007, Biocatalysis in the Pharma and Biotech Industries, 699
- Hutt, 2003, The chiral switch: The development of single enantiomer drugs from racemates, Acta Fac. Pharm. Univ. Comen., 50, 7
- 2018, Chemaxon Calculator Plugins
Cited by
Phenols in Pharmaceuticals: Analysis of a Recurring Motif
Scott, K. A., Cox, P. B., & Njardarson, J. T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00223 · Cited by 206
Exploring Electrochemical C(sp 3 )–H Oxidation for the Late-Stage Methylation of Complex Molecules
Novaes, L. F. T., Ho, J. S. K., Mao, K., Liu, K., Tanwar, M., Neurock, M., Villemure, E., Terrett, J. A., & Lin, S. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09412 · Cited by 168
Pyrazine and Phenazine Heterocycles: Platforms for Total Synthesis and Drug Discovery
Huigens, R. W., Brummel, B. R., Tenneti, S., Garrison, A. T., & Xiao, T. (2022) · Molecules · doi:10.3390/molecules27031112 · Cited by 87
Click 1,2,3-triazoles in drug discovery and development: From the flask to the clinic?
Serafini, M. T., Pirali, T., & Tron, G. C. (2020) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2020.10.001 · Cited by 49
Self-citationPharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“N 2 O is one of the World Health Organization’s essential medicines, and its clinical administration has been considered safe for more than 150 years [125].”
Background
Metadata
- Authors
- Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Corresponding author
- Pirali, Tracey
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-04-30
- Volume
- 63
- Issue
- 18
- Pages
- 10170-10187
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC8007110
- OpenAlex
- W3021755458
- Cited by
- 46
- References
- 67
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 12 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 3
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Funders
- Ministero dell???Istruzione, dell???Universit?? e della Ricerca (2017CBNCYT, 2017WJZ9W9)
- Associazione Italiana per la Ricerca sul Cancro (22568)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Medical and Pharmaceutic Studies
- Keywords
- essential medicines, WHO Model List of Essential Medicines, small molecules, stereochemistry, drug-likeness, pharmaceutical R&D, drug selection, cost-effectiveness
- MeSH terms
- Administration, Oral, Chemistry, Pharmaceutical, Formularies as Topic, Humans, Injections, Stereoisomerism, World Health Organization, Molecular Structure, Drugs, Essential
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Essential Medicinal Chemistry of Essential Medicines. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c00415
- The paper
- Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A. (2020). Essential Medicinal Chemistry of Essential Medicines. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c00415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.